Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 859

1.

Wilson Disease With Giant Splenic Artery Aneurysms Caused by Fibromuscular Dysplasia During Living Donor Liver Transplantation: A Case Report.

Sakamoto K, Ogawa K, Tamura K, Ueno Y, Inoue H, Nakamura T, Watanabe J, Takai A, Tohyama T, Senba H, Yoshida O, Abe M, Hiasa Y, Kitazawa R, Kitazawa S, Takada Y.

Transplant Proc. 2019 Oct 11. pii: S0041-1345(19)30842-5. doi: 10.1016/j.transproceed.2019.06.005. [Epub ahead of print]

PMID:
31611120
2.

Intranasal vaccination with HBs and HBc protein combined with carboxyl vinyl polymer induces strong neutralizing antibody, anti-HBs IgA, and IFNG response.

Sanada T, Yamamoto N, Kayesh MEH, Tsukiyama-Kohara K, Hasegawa H, Miyazaki T, Takano JI, Shiogama Y, Yasutomi Y, Goh Y, Yoshida O, Hiasa Y, Kohara M.

Biochem Biophys Res Commun. 2019 Sep 30. pii: S0006-291X(19)31799-1. doi: 10.1016/j.bbrc.2019.09.072. [Epub ahead of print]

3.

Lower Incidence of In-Hospital Falls in Patients Hospitalized in Window Beds Than Nonwindow Beds.

Iwamoto J, Saeki K, Kobayashi M, Yamagami Y, Yoshida O, Kurumatani N, Obayashi K.

J Am Med Dir Assoc. 2019 Aug 22. pii: S1525-8610(19)30529-8. doi: 10.1016/j.jamda.2019.07.006. [Epub ahead of print]

PMID:
31447262
4.

Correction to: Validation trial for efficacy of ultrasonographic measurement method to predict ascitic volume using virtual ultrasonography.

Hirooka M, Koizumi Y, Imai Y, Yukimoto A, Watanabe T, Yoshida O, Abe M, Hiasa Y.

J Med Ultrason (2001). 2019 Oct;46(4):519. doi: 10.1007/s10396-019-00966-y.

PMID:
31372792
5.

Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease.

Hirooka M, Ochi H, Hiraoka A, Koizumi Y, Tanaka T, Sunago K, Yukimoto A, Imai Y, Watanabe T, Yoshida O, Abe M, Joko K, Michitaka K, Hiasa Y.

J Gastroenterol Hepatol. 2019 Jul 18. doi: 10.1111/jgh.14786. [Epub ahead of print]

PMID:
31318996
6.

The efficacy of a trauma call system: challenges in managing severe trauma at a rural emergency center without full-time emergency physicians.

Matsumoto N, Yamamoto S, Endo I, Yoshida O, Kubo M, Udaka T, Sogabe O, Maeda H, Kawata C, Kurokawa H.

Acute Med Surg. 2019 Mar 12;6(3):259-264. doi: 10.1002/ams2.406. eCollection 2019 Jul.

7.

Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma.

Koizumi Y, Hirooka M, Hiraoka A, Ochi H, Tanaka T, Yukimoto A, Imai Y, Watanabe T, Yoshida O, Miyake T, Matsuura B, Michitaka K, Joko K, Abe M, Hiasa Y.

Endocr J. 2019 Sep 28;66(9):787-792. doi: 10.1507/endocrj.EJ19-0140. Epub 2019 May 30.

8.

Identifying the origin of nitrous oxide dissolved in deep ocean by concentration and isotopocule analyses.

Toyoda S, Yoshida O, Yamagishi H, Fujii A, Yoshida N, Watanabe S.

Sci Rep. 2019 May 24;9(1):7790. doi: 10.1038/s41598-019-44224-0.

9.

Schistosomiasis Diagnosed Using Laparoscopy and Colonoscopy.

Koizumi Y, Hirooka M, Tanaka T, Sunago K, Yukimoto A, Imai Y, Watanabe T, Ishihara T, Yoshida O, Yamamoto Y, Takeshita E, Ikeda Y, Abe M, Hiasa Y.

Intern Med. 2019 Sep 1;58(17):2495-2499. doi: 10.2169/internalmedicine.2776-19. Epub 2019 May 22.

10.

Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation.

Imai Y, Yoshida O, Watanabe T, Yukimoto A, Koizumi Y, Ikeda Y, Tokumoto Y, Hirooka M, Abe M, Hiasa Y.

PLoS One. 2019 Feb 22;14(2):e0212589. doi: 10.1371/journal.pone.0212589. eCollection 2019.

11.

Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease.

Nakamura Y, Abe M, Kawasaki K, Miyake T, Watanabe T, Yoshida O, Hirooka M, Matsuura B, Hiasa Y.

Sci Rep. 2019 Jan 30;9(1):977. doi: 10.1038/s41598-018-37403-y.

12.

Impact of water exposure on skin barrier permeability and ultrastructure.

Ogawa-Fuse C, Morisaki N, Shima K, Hotta M, Sugata K, Ichihashi T, Oguri M, Yoshida O, Fujimura T.

Contact Dermatitis. 2019 Apr;80(4):228-233. doi: 10.1111/cod.13174. Epub 2018 Dec 14.

PMID:
30417381
13.

Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma.

Yukimoto A, Hirooka M, Hiraoka A, Michitaka K, Ochi H, Joko K, Imai Y, Watanabe T, Koizumi Y, Yoshida O, Abe M, Hiasa Y.

Jpn J Clin Oncol. 2019 Jan 1;49(1):42-47. doi: 10.1093/jjco/hyy153.

PMID:
30380075
14.

The Serum Creatinine Level Might Be Associated with the Onset of Impaired Fasting Glucose: A Community-based Longitudinal Cohort Health Checkup Study.

Yoshida N, Miyake T, Yamamoto S, Furukawa S, Senba H, Kanzaki S, Koizumi M, Ishihara T, Yoshida O, Hirooka M, Kumagi T, Abe M, Kitai K, Matsuura B, Hiasa Y.

Intern Med. 2019 Feb 15;58(4):505-510. doi: 10.2169/internalmedicine.0760-18. Epub 2018 Oct 17.

15.

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease.

Miyake T, Yoshida S, Furukawa S, Sakai T, Tada F, Senba H, Yamamoto S, Koizumi Y, Yoshida O, Hirooka M, Kumagi T, Niiya T, Miyaoka H, Masanori A, Matsuura B, Hiasa Y.

Open Med (Wars). 2018 Sep 14;13:402-409. doi: 10.1515/med-2018-0059. eCollection 2018.

16.

Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).

Al Mahtab M, Akbar SMF, Aguilar JC, Guillen G, Penton E, Tuero A, Yoshida O, Hiasa Y, Onji M.

PLoS One. 2018 Aug 22;13(8):e0201236. doi: 10.1371/journal.pone.0201236. eCollection 2018.

17.

Low Urine pH Is Associated with Non-alcoholic Fatty Liver Disease: A Community-based Cross-sectional Study.

Miyake T, Yoshida S, Yamamoto S, Furukawa S, Yoshida O, Kanzaki S, Senba H, Ishihara T, Koizumi M, Tokumoto Y, Hirooka M, Kumagi T, Abe M, Kitai K, Matsuura B, Hiasa Y.

Intern Med. 2018 Oct 1;57(19):2799-2805. doi: 10.2169/internalmedicine.0167-17. Epub 2018 May 18.

18.

Validation trial for efficacy of ultrasonographic measurement method to predict ascitic volume using virtual ultrasonography.

Hirooka M, Koizumi Y, Imai Y, Yukimoto A, Watanabe T, Yoshida O, Abe M, Hiasa Y.

J Med Ultrason (2001). 2018 Oct;45(4):555-564. doi: 10.1007/s10396-018-0879-9. Epub 2018 Apr 18. Erratum in: J Med Ultrason (2001). 2019 Aug 1;:.

PMID:
29671146
19.

Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study.

Okamoto M, Miyake T, Kitai K, Furukawa S, Yamamoto S, Senba H, Kanzaki S, Deguchi A, Koizumi M, Ishihara T, Miyaoka H, Yoshida O, Hirooka M, Kumagi T, Abe M, Matsuura B, Hiasa Y.

PLoS One. 2018 Apr 17;13(4):e0195147. doi: 10.1371/journal.pone.0195147. eCollection 2018.

20.

Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease.

Hirooka M, Koizumi Y, Miyake T, Watanabe T, Yoshida O, Tokumoto Y, Yukimoto A, Nakamura Y, Imai Y, Abe M, Hiasa Y.

Hepatol Commun. 2017 Jul 27;1(7):623-633. doi: 10.1002/hep4.1070. eCollection 2017 Sep.

21.

Decreased daytime light intensity at nonwindow hospital beds: Comparisons with light intensity at window hospital beds and light exposure in nonhospitalized elderly individuals.

Iwamoto J, Obayashi K, Kobayashi M, Kotsuji T, Matsui R, Ito K, Yoshida O, Kurumatani N, Saeki K.

Chronobiol Int. 2018 May;35(5):719-723. doi: 10.1080/07420528.2018.1430036. Epub 2018 Jan 26.

PMID:
29372842
22.

Relationship between urine pH and abnormal glucose tolerance in a community-based study.

Yoshida S, Miyake T, Yamamoto S, Furukawa S, Niiya T, Senba H, Kanzaki S, Yoshida O, Ishihara T, Koizumi M, Hirooka M, Kumagi T, Abe M, Kitai K, Matsuura B, Hiasa Y.

J Diabetes Investig. 2018 Jul;9(4):769-775. doi: 10.1111/jdi.12777. Epub 2017 Dec 18.

23.

Usefulness of laparoscopy and intraductal ultrasonography in a patient with isolated immunoglobulin G4-related sclerosing cholangitis.

Ohno Y, Kumagi T, Imamura Y, Kuroda T, Koizumi M, Watanabe T, Yoshida O, Tokumoto Y, Takeshita E, Abe M, Harada K, Hiasa Y.

Clin J Gastroenterol. 2018 Feb;11(1):62-68. doi: 10.1007/s12328-017-0787-3. Epub 2017 Nov 1.

PMID:
29094322
24.

Quantitative imaging of fibrotic and morphological changes in liver of non-alcoholic steatohepatitis (NASH) model mice by second harmonic generation (SHG) and auto-fluorescence (AF) imaging using two-photon excitation microscopy (TPEM).

Yamamoto S, Oshima Y, Saitou T, Watanabe T, Miyake T, Yoshida O, Tokumoto Y, Abe M, Matsuura B, Hiasa Y, Imamura T.

Biochem Biophys Rep. 2016 Sep 25;8:277-283. doi: 10.1016/j.bbrep.2016.09.010. eCollection 2016 Dec.

25.

Graft-infiltrating PD-L1hi cross-dressed dendritic cells regulate antidonor T cell responses in mouse liver transplant tolerance.

Ono Y, Perez-Gutierrez A, Nakao T, Dai H, Camirand G, Yoshida O, Yokota S, Stolz DB, Ross MA, Morelli AE, Geller DA, Thomson AW.

Hepatology. 2018 Apr;67(4):1499-1515. doi: 10.1002/hep.29529. Epub 2018 Feb 18.

26.

Influence of the Novel ATP-Competitive Dual mTORC1/2 Inhibitor AZD2014 on Immune Cell Populations and Heart Allograft Rejection.

Fantus D, Dai H, Ono Y, Watson A, Yokota S, Mohib K, Yoshida O, Ross MA, Watkins SC, Ramaswami B, Valusjkikh A, Rothstein DM, Thomson AW.

Transplantation. 2017 Dec;101(12):2830-2840. doi: 10.1097/TP.0000000000001933.

27.

Pharmacological evaluation of novel (6-aminopyridin-3-yl)(4-(pyridin-2-yl)piperazin-1-yl) methanone derivatives as TRPV4 antagonists for the treatment of pain.

Tsuno N, Yukimasa A, Yoshida O, Suzuki S, Nakai H, Ogawa T, Fujiu M, Takaya K, Nozu A, Yamaguchi H, Matsuda H, Funaki S, Yamanada N, Tanimura M, Nagamatsu D, Asaki T, Horita N, Yamamoto M, Hinata M, Soga M, Imai M, Morioka Y, Kanemasa T, Sakaguchi G, Iso Y.

Bioorg Med Chem. 2017 Apr 1;25(7):2177-2190. doi: 10.1016/j.bmc.2017.02.047. Epub 2017 Mar 1.

PMID:
28284871
28.

Clinical utility of multipolar ablation with a 3-D simulator system for patients with liver cancer.

Hirooka M, Koizumi Y, Imai Y, Nakamura Y, Yukimoto A, Watanabe T, Yoshida O, Tokumoto Y, Abe M, Hiasa Y.

J Gastroenterol Hepatol. 2017 Nov;32(11):1852-1858. doi: 10.1111/jgh.13772.

PMID:
28240420
29.

Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinoma.

Imai Y, Hirooka M, Koizumi Y, Nakamura Y, Watanabe T, Yoshida O, Tokumoto Y, Takeshita E, Abe M, Tanaka H, Kurata M, Kitazawa S, Hiasa Y.

Radiol Case Rep. 2016 Dec 27;12(1):179-184. doi: 10.1016/j.radcr.2016.11.006. eCollection 2017 Mar.

30.

A case of an unruptured hepatic aneurysm on the common hepatic artery at the junction of the gastroduodenal and proper hepatic arteries treated with transcatheter arterial embolization.

Imai Y, Hirooka M, Koizumi Y, Nakamura Y, Watanabe T, Yoshida O, Tokumoto Y, Takeshita E, Abe M, Hiasa Y.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(1):99-103. doi: 10.11405/nisshoshi.114.99. Japanese.

PMID:
28070101
31.

Comparison between real-time tissue elastography and vibration-controlled transient elastography for the assessment of liver fibrosis and disease progression in patients with primary biliary cholangitis.

Koizumi Y, Hirooka M, Abe M, Tokumoto Y, Yoshida O, Watanabe T, Nakamura Y, Imai Y, Yukimoto A, Kumagi T, Takeshita E, Ikeda Y, Hiasa Y.

Hepatol Res. 2017 Nov;47(12):1252-1259. doi: 10.1111/hepr.12861. Epub 2017 Feb 7.

PMID:
28044427
32.

Skeletal muscle derived stem cells microintegrated into a biodegradable elastomer for reconstruction of the abdominal wall.

Takanari K, Hashizume R, Hong Y, Amoroso NJ, Yoshizumi T, Gharaibeh B, Yoshida O, Nonaka K, Sato H, Huard J, Wagner WR.

Biomaterials. 2017 Jan;113:31-41. doi: 10.1016/j.biomaterials.2016.10.029. Epub 2016 Oct 18.

PMID:
27810640
33.

Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.

Miyake T, Kumagi T, Hirooka M, Furukawa S, Yoshida O, Koizumi M, Yamamoto S, Watanabe T, Yamamoto Y, Tokumoto Y, Takeshita E, Abe M, Kitai K, Matsuura B, Hiasa Y.

J Gastroenterol. 2016 Nov;51(11):1090-1100. Epub 2016 Mar 12.

PMID:
26971094
34.

Discovery of novel 2',4'-dimethyl-[4,5'-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 1.

Tsuno N, Yukimasa A, Yoshida O, Ichihashi Y, Inoue T, Ueno T, Yamaguchi H, Matsuda H, Funaki S, Yamanada N, Tanimura M, Nagamatsu D, Nishimura Y, Ito T, Soga M, Horita N, Yamamoto M, Hinata M, Imai M, Morioka Y, Kanemasa T, Sakaguchi G, Iso Y.

Bioorg Med Chem Lett. 2016 Oct 15;26(20):4930-4935. doi: 10.1016/j.bmcl.2016.09.013. Epub 2016 Sep 7.

PMID:
27637151
35.

Discovery of novel 2',4'-dimethyl-[4,5'-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 2.

Tsuno N, Yukimasa A, Yoshida O, Suzuki S, Nakai H, Ogawa T, Fujiu M, Takaya K, Nozu A, Yamaguchi H, Matsuda H, Funaki S, Nishimura Y, Ito T, Nagamatsu D, Asaki T, Horita N, Yamamoto M, Hinata M, Soga M, Imai M, Morioka Y, Kanemasa T, Sakaguchi G, Iso Y.

Bioorg Med Chem Lett. 2016 Oct 15;26(20):4936-4941. doi: 10.1016/j.bmcl.2016.09.014. Epub 2016 Sep 7.

PMID:
27634196
36.

Nucleoid clumping is dispensable for the Dps-dependent hydrogen peroxide resistance in Staphylococcus aureus.

Ushijima Y, Yoshida O, Villanueva MJ, Ohniwa RL, Morikawa K.

Microbiology. 2016 Oct;162(10):1822-1828. doi: 10.1099/mic.0.000353. Epub 2016 Aug 17.

PMID:
27539241
37.

Hyperthyroidism Improves the Pathological Condition of Nonalcoholic Steatohepatitis: A Case of Nonalcoholic Steatohepatitis with Graves' Disease.

Miyake T, Matsuura B, Furukawa S, Todo Y, Yamamoto S, Yoshida O, Imai Y, Watanabe T, Yamamoto Y, Hirooka M, Tokumoto Y, Kumagi T, Abe M, Seike H, Miyauchi S, Hiasa Y.

Intern Med. 2016;55(15):2019-23. doi: 10.2169/internalmedicine.55.6640. Epub 2016 Aug 1.

38.

[Clinicopathological Study of Small Intestinal Carcinoma].

Udaka T, Matsumoto N, Endo I, Yamamoto S, Yoshida O, Inokawa H, Kubo A, Mizuta M.

Gan To Kagaku Ryoho. 2016 Jul;43(7):897-900. Japanese.

PMID:
27431637
39.

Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels.

Miyake T, Hirooka M, Yoshida O, Furukawa S, Kumagi T, Koizumi M, Yamamoto S, Kuroda T, Arimitsu E, Takeshita E, Abe M, Kitai K, Matsuura B, Hiasa Y.

J Gastroenterol. 2017 Feb;52(2):237-244. doi: 10.1007/s00535-016-1234-9. Epub 2016 Jun 24.

PMID:
27342127
40.

Orthotopic mouse liver transplantation to study liver biology and allograft tolerance.

Yokota S, Ueki S, Ono Y, Kasahara N, Pérez-Gutiérrez A, Kimura S, Yoshida O, Murase N, Yasuda Y, Geller DA, Thomson AW.

Nat Protoc. 2016 Jul;11(7):1163-74. doi: 10.1038/nprot.2016.073. Epub 2016 Jun 2.

PMID:
27254462
41.

[Clinicopathological Outcome of Perforated Colorectal Cancer].

Udaka T, Matsumoto N, Endo I, Yamamoto S, Yoshida O, Inokawa H, Kubo M, Mizuta M.

Gan To Kagaku Ryoho. 2016 Apr;43(4):439-42. Japanese.

PMID:
27220789
42.

The usefulness of resuscitative endovascular balloon occlusion of the aorta in detecting the source of a hemorrhage due to abdominal blunt trauma.

Matsumoto N, Sogabe O, Yoshida O, Endo I, Yamamoto S, Inokawa H, Kubo M, Udaka T, Maeda H, Mizuta M.

Am J Emerg Med. 2016 Oct;34(10):2057.e1-2057.e3. doi: 10.1016/j.ajem.2016.03.026. Epub 2016 Mar 14. No abstract available.

PMID:
27103083
43.

Assessment of a needle-tracking system for bipolar radiofrequency ablation.

Hirooka M, Koizumi Y, Imai Y, Ochi H, Nakamura Y, Yoshida O, Hiraoka A, Tokumoto Y, Abe M, Hiasa Y.

J Med Ultrason (2001). 2016 Apr;43(2):185-91. doi: 10.1007/s10396-015-0679-4. Epub 2015 Oct 26.

PMID:
27033864
44.

Preoperative Differential Diagnosis of Canine Adrenal Tumors Using Triple-Phase Helical Computed Tomography.

Yoshida O, Kutara K, Seki M, Ishigaki K, Teshima K, Ishikawa C, Iida G, Edamura K, Kagawa Y, Asano K.

Vet Surg. 2016 May;45(4):427-35. doi: 10.1111/vsu.12462. Epub 2016 Mar 23.

PMID:
27007886
45.

Usefulness of a New Three-Dimensional Simulator System for Radiofrequency Ablation.

Hirooka M, Koizumi Y, Imai Y, Miyake T, Watanabe T, Yoshida O, Takeshita E, Tokumoto Y, Abe M, Hiasa Y.

PLoS One. 2016 Feb 4;11(2):e0148298. doi: 10.1371/journal.pone.0148298. eCollection 2016.

46.

Liver transplantation in the mouse: Insights into liver immunobiology, tissue injury, and allograft tolerance.

Yokota S, Yoshida O, Ono Y, Geller DA, Thomson AW.

Liver Transpl. 2016 Apr;22(4):536-46. doi: 10.1002/lt.24394. Review.

47.

Novel insights into immunotherapy for hepatitis B patients.

Akbar SM, Al-Mahtab M, Jahan M, Yoshida O, Hiasa Y.

Expert Rev Gastroenterol Hepatol. 2016;10(2):267-76. doi: 10.1586/17474124.2016.1112266. Epub 2015 Dec 2. Review.

PMID:
26626120
48.

Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.

Watanabe T, Tokumoto Y, Joko K, Michitaka K, Mashiba T, Hiraoka A, Ochi H, Koizumi Y, Tada F, Hirooka M, Yoshida O, Imai Y, Abe M, Hiasa Y.

Hepatol Int. 2016 Mar;10(2):320-7. doi: 10.1007/s12072-015-9647-8. Epub 2015 Jul 22.

PMID:
26198757
49.

Early Growth Response-1 Plays an Important Role in Ischemia-Reperfusion Injury in Lung Transplants by Regulating Polymorphonuclear Neutrophil Infiltration.

Yamamoto S, Yamane M, Yoshida O, Waki N, Okazaki M, Matsukawa A, Oto T, Miyoshi S.

Transplantation. 2015 Nov;99(11):2285-93. doi: 10.1097/TP.0000000000000783.

PMID:
26079744
50.

IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα production.

Yokota S, Yoshida O, Dou L, Spadaro AV, Isse K, Ross MA, Stolz DB, Kimura S, Du Q, Demetris AJ, Thomson AW, Geller DA.

J Immunol. 2015 Jun 15;194(12):6045-56. doi: 10.4049/jimmunol.1402505. Epub 2015 May 11.

Supplemental Content

Loading ...
Support Center